.png?sfvrsn=87c1dfdf_1)
| 1ST APCC SCIENTIFIC COMMITTEE 2026 | |
 Prof Doris Young | Prof Young is the inaugural Head of the Department of Family Medicine at NUHS. She has extensive experience in educating and training medical students, residents, general practitioners, and other health professionals in adolescent medicine, general practice, and primary care research. Her research focuses on trialling innovative models of care in the primary care setting to improve health outcomes for people with chronic diseases, particularly diabetes mellitus. |
 Adj A/Prof Chee Cheng Ean | Adj A/Prof Chee Cheng Ean is the Executive Director of the National University Cancer Institute, Singapore. In this role, she provides leadership and direction, facilitates operations and is responsible for implementing strategic initiatives for NCIS (pronounced N-CIS), which is the only public, academic cancer center in Singapore treating both pediatric and adult cancers in one facility.
|
 A/Prof Sarah Bailey Visiting Professor, Dept of Family Medicine, Yong Loo Lin School of Medicine, National University Singapore (NUS) | Prof Sarah is an academic working at the interface of primary care, cancer epidemiology, and health systems, with a focus on improving early cancer detection in real-world practice. Her work centres on identifying and translating clinically actionable signals of cancer risk - particularly using electronic health record data - and ensuring these insight meaningfully influence clinical decision making, policy, and patient outcomes. A core theme to her programme of work is bridging the gap between evidence generation and implementation. She has experience of leading multi-disciplinary research teams, mentoring early- and mid-career colleagues, and working in close partnership with the UK National Health Service, commercial partners, and community groups. Alongside her academic work, she is actively engaged in international collaboration, public and professional education, and translational initiatives aimed at bringing research into practice at scale. Her long term ambition is to build sustainable, globally relevant programmes of work in early cancer detection that combine scientific rigour, clinical relevance, and societal impact. |
 Prof John Emery | Prof John Emery is the Professor of Family Medicine and Director of the recently established Centre for Cancer Prevention and Early Detection at the Lee Kong Chian School of Medicine, Nanyang Technological University. He was previously the Professor of Primary Care Cancer Research at the University of Melbourne where he remains an Honorary Professor. Prof John Emery is an internationally recognised leader in primary care cancer research with specific expertise in the development and evaluation of complex interventions including novel cancer diagnostic and screening technologies, clinical translation of genomics, computer decision support systems, models of cancer survivorship, and use of linked healthcare data to study variations in cancer care. Following his medical training at Cambridge and Oxford, he has had a highly successful career in academic primary care, initially at Oxford, where he obtained his DPhil on cancer risk assessment tools, then as a Cancer Research UK Clinician Scientist at Cambridge before taking up a Chair at the University of Western Australia. He moved to the University of Melbourne in 2013 for a Chair linked to the establishment of the Victorian Comprehensive Cancer Centre where he led the creation of one of the largest cancer in primary care research groups in the world. |
 Adj A/Prof Samuel Ow Senior Consultant, Dept of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS) |
Adj A/Prof Samuel Ow is Senior Consultant Medical Oncologist at the Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS). He obtained his medical degree from the Yong Loo Lin School of Medicine, National University of Singapore, where he was awarded Distinction in Medicine, the Nestle Gold Medal, and placed on the Dean's List for his academic achievements. He received the Dean's Award for Outstanding House Officer of his entire cohort, and obtained the Masters of Medicine (Internal Medicine) and Membership of the Royal College of Physicians (UK) on an MOHH Postgraduate Exam Scholarship. He subsequently successfully completed his specialty training in Internal Medicine and Medical Oncology at NCIS where he served as Chief Registrar and was also selected for the inaugural Singapore Chief Residency Program. Adj A/Prof Samuel Ow's clinical and research interests are in Breast Cancer and Clinical Cancer Genetics. He received a Master of Public Heath with concentration in Epidemiology and Biostatistics from the Johns Hopkins Bloomberg School of Public Health on an Academic Medicine Development Award. He is principal / co-investigator in multiple investigator-initiated and international clinical trials and has published his research in peer-reviewed journals. He is an alumnus of the Clinical Cancer Genetics Community of Practice Intensive Course in Cancer Risk Assessment conducted by the City of Hope Comprehensive Cancer Centre, and currently runs the Cancer Genetics Clinic at NCIS. In addition to his clinical work, Adj A/Prof Samuel Ow leads the National Shared Care Initiative for Cancer Survivorship across all three healthcare clusters, which aims to transit the care of cancer survivors to the community. He is a strong advocate in improving access to care and support for cancer survivors and serves as a Council Member of the Singapore Cancer Society. He also sits on the committee for the National Breast Cancer Awareness Month Campaign to help drive greater awareness for breast cancer screening and prevention in the general public. Adj A/Prof Samuel Ow strongly believes in the importance of training the next generation of physicians and was previously Associate Program Director of the Medical Oncology Senior Residency Program at NCIS. He is an Adjunct Associate Professor on the Clinician-Educator track at the Yong Loo Lin School of Medicine, and currently sits in the national Residency Advisory Committee for Medical Oncology. He is active in medical education at the undergraduate and postgraduate level and has been awarded for teaching excellence. On the administrative front, Adj A/Prof Samuel Ow serves as Clinical Director of the Department of Haematology-Oncology and is involved in improving processes to enhance clinical care in cancer patients. He is an advocate for multidisciplinary collaboration, and notably led a team from NCIS to win the Best Practice Medal (Care Redesign Category) at the National Healthcare Innovation and Productivity Medals. |
